Teva Pharmaceutical Industries Ltd TEVA:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 04/18/24 EDT

12.78

-0.40 (-3.03%)

Volume

8,867,034

52 week range

7.09 - 14.47

Open0.00
Day High0.00
Day Low0.00
Prev Close12.78
52 Week High14.47
52 Week High Date04/08/24
52 Week Low7.09
52 Week Low Date05/31/23

Key Stats

Market Cap14.326B
Shares Out1.12B
10 Day Average Volume9.36M
Dividend-
Dividend Yield-
Beta1.07
YTD % Change22.41

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close12.78
52 Week High14.47
52 Week High Date04/08/24
52 Week Low7.09
52 Week Low Date05/31/23
Market Cap14.326B
Shares Out1.12B
10 Day Average Volume9.36M
Dividend-
Dividend Yield-
Beta1.07
YTD % Change22.41

RATIOS/PROFITABILITY

EPS (TTM)-0.50
P/E (TTM)-25.53
Fwd P/E (NTM)5.33
EBITDA (TTM)4.803B
ROE (TTM)-7.30%
Revenue (TTM)15.846B
Gross Margin (TTM)50.33%
Net Margin (TTM)-3.90%
Debt To Equity (MRQ)264.23%

EVENTS

Earnings Date05/08/2024
Ex Div Date11/27/2017
Div Amount0.085
Split Date-
Split Factor-

Latest On Teva Pharmaceutical Industries Ltd

Lightning Round: Buy Eli Lilly instead of Novo, says Jim CramerMarch 22, 2024CNBC.com
Cramer's Lighting Round: Arm is a buyMarch 22, 2024CNBC.com

Content From Our Affiliates

Teva Pharmaceutical Revamps Financial Reporting Structure11 Hours AgoTipRanks
Teva and Alvotech announce FDA approved SELARSDI injectionApril 16, 2024TipRanks
Teva announces final results from the HD cohort study for Austedo at AANApril 16, 2024TipRanks
Pfizer (NYSE:PFE) Settlement Sends Shares Up SlightlyApril 11, 2024TipRanks
Teva announces AJOVY study met all critical efficacy endpoints in China trialApril 11, 2024TipRanks

Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract...

Sol Barer

Independent Chairman of the Board

Richard Francis

President, Chief Executive Officer

Eliyahu Kalif

Chief Financial Officer, Executive Vice President

David Stark

Executive Vice President, Chief Legal Officer

Christine Fox

Executive Vice President - U.S. Commercial

Address

124 Dvora Hanevi'a St

Tel Aviv-yafo

6944020

Israel

https://www.tevapharm.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
VTRS Viatris Inc	11.12	+0.02	+0.18%
HLN HALEON PLC	8.13	+0.02	+0.25%
CTLT Catalent Inc	55.80	-0.16	-0.29%
OGN Organon & Co	17.86	-0.01	-0.06%
RPRX Royalty Pharma PLC	27.89	+0.28	+1.01%